NDC 81033-031-05 - Hydroxyzine Hydrochloride
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 81033-031
- Requested NDC
- 81033-031-05
- Package NDCs from labels
- 81033-031-05, 81033-031-44, 81033-031-12, 81033-031-45
- Manufacturer
- Kesin Pharma
- Effective date
- 2026-03-10
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Hydroxyzine Hydrochloride - Kesin Pharma | Kesin Pharma | 2026-03-10 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 81033-031-05 | Hydroxyzine Hydrochloride | 5 mL in 1 CUP, UNIT-DOSE | SOLUTION | 5 | 2 | |
| 81033-031-12 | Hydroxyzine Hydrochloride | 12.5 mL in 1 CUP, UNIT-DOSE | SOLUTION | 12.5 | 2 | |
| 81033-031-44 | Hydroxyzine Hydrochloride | 40 in 1 CARTON | SOLUTION | 40 | 2 | |
| 81033-031-45 | Hydroxyzine Hydrochloride | 40 in 1 CARTON | SOLUTION | 40 | 2 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 81033-031-05 | ML - Milliliter | 81033-031 | d792c426-65f3-4a59-bc7c-da089105f7be | 1 | 2026-04-20 |
| 81033-031-12 | ML - Milliliter | 81033-031 | d75e6d7f-abba-4225-9f70-bb18b58d6ea3 | 1 | 2026-04-20 |
| 81033-031-44 | ML - Milliliter | 81033-031 | c0a022c7-f081-46f7-81ce-460abec27ed9 | 1 | 2026-04-20 |
| 81033-031-45 | ML - Milliliter | 81033-031 | 1f586e30-cc21-4d11-91f3-2897b6cb3418 | 1 | 2026-04-20 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Sodium phenylacetate and Sodium benzoate | SODIUM PHENYLACETATE AND SODIUM BENZOATE | Navinta LLC | d20768fe-4516-483a-a082-ff1df9ad1d99 | 2025-12-06 | Warnings, Adverse reactions | OJ245FE5EU |
| Alka-Seltzer Extra Strength | ANHYDROUS CITRIC ACID, SODIUM BICARBONATE, AND ASPIRIN | Bayer HealthCare LLC. | 49b73bd5-6465-05eb-e054-00144ff88e88 | 2025-12-04 | Warnings | XF417D3PSL |
| Alka-Seltzer Original | ANHYDROUS CITRIC ACID, ASPIRIN, AND SODIUM BICARBONATE | Bayer HealthCare LLC. | 5be36a7f-7d1f-468d-9c29-92c8cd3ef1bc | 2025-12-04 | Warnings | XF417D3PSL |
| Hydroxyzine Hydrochloride | HYDROXYZINE HYDROCHLORIDE | Bryant Ranch Prepack | 3526a66b-2182-4b5a-a7d1-563d75f5335f | 2025-12-03 | Warnings, Adverse reactions | 76755771U3 |
| Hydroxyzine Hydrochloride | HYDROXYZINE HYDROCHLORIDE | Bryant Ranch Prepack | 9504897e-febc-4293-a2dc-9f79f55ea821 | 2025-12-03 | Warnings, Adverse reactions | 76755771U3 |
| HYDROXYZINE HYDROCHLORIDE | HYDROXYZINE HYDROCHLORIDE | A-S Medication Solutions | afa74394-c079-4ad3-b555-270fe0de3d62 | 2025-12-02 | Warnings, Adverse reactions | 76755771U3 |
| HYDROXYZINE HYDROCHLORIDE | HYDROXYZINE HYDROCHLORIDE | A-S Medication Solutions | 69a58bc6-c8a4-48ad-ac77-90fac42e0398 | 2025-12-02 | Warnings, Adverse reactions | 76755771U3 |
| HYDROXYZINE HYDROCHLORIDE | HYDROXYZINE HYDROCHLORIDE | A-S Medication Solutions | a8525244-2acb-4e3e-9769-bbc90549a188 | 2025-12-02 | Warnings, Adverse reactions | 76755771U3 |
| HYDROXYZINE HYDROCHLORIDE | HYDROXYZINE HYDROCHLORIDE | A-S Medication Solutions | 87b79b7c-0398-47dc-858d-62e44a1b02f4 | 2025-12-02 | Warnings, Adverse reactions | 76755771U3 |
| ACD-A | ANTICOAGULANT CITRATE DEXTROSE SOLUTION FORMULA A | Fenwal, Inc. | ab19b011-0a51-4f04-9881-d9fc7cae95ae | 2025-11-25 | XF417D3PSL | |
| PUR-WASH | WATER | Niagara Pharmaceuticals Inc. | beda35c3-9a8b-47ad-e053-2995a90a7b1b | 2025-11-24 | Warnings | 059QF0KO0R |
| Easy Care First Aid Eyewash | WATER | Tender Corporation | a070aac8-e6d2-ef10-e053-2a95a90aa5b1 | 2025-11-24 | Warnings | 059QF0KO0R |
| PUR-WASH | WATER | Niagara Pharmaceuticals Inc. | e07a064b-f680-405c-bbcd-24fac430951e | 2025-11-24 | Warnings | 059QF0KO0R |
| ULINE Eyewash | EYEWASH | Niagara Pharmaceuticals Inc. | 2d7f22d2-320b-6af1-e063-6294a90addc6 | 2025-11-24 | Warnings | 059QF0KO0R |
| Pur-Wash | EYEWASH | Niagara Pharmaceuticals, Inc. | 0d43b1c1-2699-37f1-e054-00144ff88e88 | 2025-11-24 | Warnings | 059QF0KO0R |
| PUR-WASH | WATER | Niagara Pharmaceuticals Inc. | 777e1559-786f-8d54-e053-2991aa0aa98d | 2025-11-24 | Warnings | 059QF0KO0R |
| PUR-WASH | WATER | Niagara Pharmaceuticals Inc. | 7289103a-5cbf-42f4-8848-e827149a43ca | 2025-11-24 | Warnings | 059QF0KO0R |
| Eyewash Additive Concentrate | WATER AND PROPYLENE GLYCOL | Haws Corporation | dd168403-398c-41ff-b1df-d93e4ff39de3 | 2025-11-20 | Warnings | 059QF0KO0R |
| HydrOXYzine Hydrochloride | HYDROXYZINE HYDROCHLORIDE | NuCare Pharmaceuticals,Inc. | acc99b8f-87f0-eb3a-e053-2995a90aaaed | 2025-11-20 | Warnings, Adverse reactions | 76755771U3 |
| Sterile Water | WATER | Fresenius Kabi USA, LLC | fd823bef-c14c-4708-a18a-8aaa8470412f | 2025-11-18 | Warnings, Adverse reactions | 059QF0KO0R |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.